Author Topic: FDA considering major shift in COVID vaccine strategy  (Read 21 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9842
  • MS diagnosed 1980
  • Location: Pacific Northwest
FDA considering major shift in COVID vaccine strategy
« on: January 29, 2023, 09:27:30 pm »
From NPR (January 23, 2023)--"FDA Considers Major Shift in COVID Vaccine Strategy":


https://www.npr.org/sections/health-shots/2023/01/23/1150032238/fda-considers-major-shift-in-covid-vaccine-strategy
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
93 Views
Last post February 14, 2017, 03:05:17 pm
by agate
0 Replies
37 Views
Last post October 04, 2020, 09:25:32 pm
by agate
0 Replies
60 Views
Last post January 13, 2021, 02:32:50 pm
by agate
0 Replies
40 Views
Last post February 08, 2021, 09:19:10 pm
by agate
0 Replies
24 Views
Last post July 31, 2022, 09:24:13 pm
by agate